{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:32:04Z","timestamp":1780605124139,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 CA087971"],"award-info":[{"award-number":["P01 CA087971"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.imlet.2015.05.009","type":"journal-article","created":{"date-parts":[[2015,5,18]],"date-time":"2015-05-18T06:01:44Z","timestamp":1431928904000},"page":"28-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Surgical cytoreduction restores the antitumor efficacy of a Listeria monocytogenes vaccine in malignant pleural mesothelioma"],"prefix":"10.1016","volume":"166","author":[{"given":"Gregory T.","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan F.","family":"Judy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratik","family":"Bhojnagarwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund K.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zvi G.","family":"Fridlender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Albelda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.imlet.2015.05.009_bib0250","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ccm.2012.12.005","article-title":"Malignant pleural mesothelioma: Update on treatment options with a focus on novel therapies","volume":"34","author":"Haas","year":"2013","journal-title":"Clin. Chest Med."},{"issue":"6","key":"10.1016\/j.imlet.2015.05.009_bib0255","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ctrv.2012.12.005","article-title":"Malignant mesothelioma: New insights into a rare disease","volume":"39","author":"Remon","year":"2013","journal-title":"Cancer Treat. Rev."},{"issue":"18","key":"10.1016\/j.imlet.2015.05.009_bib0260","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","article-title":"Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma","volume":"27","author":"Krug","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.imlet.2015.05.009_bib0265","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1556-0864(15)31583-5","article-title":"Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: A phase II trial","volume":"1","author":"Flores","year":"2006","journal-title":"J. Thorac. Oncol."},{"issue":"15","key":"10.1016\/j.imlet.2015.05.009_bib0270","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.imlet.2015.05.009_bib0275","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1164\/rccm.200909-1465OC","article-title":"Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma","volume":"181","author":"Hegmans","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.imlet.2015.05.009_bib0280","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.4049\/jimmunol.170.10.4905","article-title":"Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8T cells","volume":"170","author":"Nowak","year":"2003","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2015.05.009_bib0285","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.lungcan.2006.01.007","article-title":"Recombinant GM-CSF plus autologous tumor cells as a vaccine for patients with mesothelioma","volume":"52","author":"Powell","year":"2006","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.imlet.2015.05.009_bib0290","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1165\/rcmb.2013-0472TR","article-title":"Immunotherapy for malignant pleural mesothelioma. Current status and future prospects","volume":"50","author":"Wong","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"12 Pt 1","key":"10.1016\/j.imlet.2015.05.009_bib0295","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1158\/1078-0432.CCR-03-0801","article-title":"A new target for immunotherapy","volume":"10","author":"Hassan","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.imlet.2015.05.009_bib0300","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejca.2007.08.028","article-title":"Mesothelin targeted cancer immunotherapy","volume":"44","author":"Hassan","year":"2008","journal-title":"Eur. J. Cancer"},{"issue":"9396","key":"10.1016\/j.imlet.2015.05.009_bib0305","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(03)14794-0","article-title":"Mesothelin-family proteins and diagnosis of mesothelioma","volume":"362","author":"Robinson","year":"2003","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.imlet.2015.05.009_bib0310","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1158\/0008-5472.CAN-14-0337","article-title":"Discovery of mesothelin and exploiting it as a target for immunotherapy","volume":"74","author":"Pastan","year":"2014","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.imlet.2015.05.009_bib0315","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1440-1843.2005.00714.x","article-title":"Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma","volume":"10","author":"Sterman","year":"2005","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.imlet.2015.05.009_bib0320","first-page":"466","article-title":"Mesothelin-targeted immunotherapies for malignant pleural mesothelioma","volume":"1","author":"Villena-Vargas","year":"2012","journal-title":"Ann. Cardiothorac. Surg."},{"key":"10.1016\/j.imlet.2015.05.009_bib0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1586\/14737140.2014.919859","article-title":"Immune therapies for malignant mesothelioma","volume":"14","author":"Antoniu","year":"2014","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"2","key":"10.1016\/j.imlet.2015.05.009_bib0330","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11864-011-0149-1","article-title":"Novel targeted therapies and vaccination strategies for mesothelioma","volume":"12","author":"Bagia","year":"2011","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.imlet.2015.05.009_bib0335","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/B978-0-12-407190-2.00007-1","article-title":"Therapeutic cancer vaccines: Past, present, and future","volume":"119","author":"Guo","year":"2013","journal-title":"Adv. Cancer Res."},{"issue":"1","key":"10.1016\/j.imlet.2015.05.009_bib0340","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.canlet.2012.02.034","article-title":"Immunity and malignant mesothelioma: From mesothelial cell damage to tumor development and immune response-based therapies","volume":"322","author":"Izzi","year":"2012","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.imlet.2015.05.009_bib0345","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djs033","article-title":"Therapeutic cancer vaccines: Current status and moving forward","volume":"104","author":"Schlom","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.imlet.2015.05.009_bib0350","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0065-2776(08)60911-6","article-title":"Escape of human solid tumors from T-cell recognition: Molecular mechanisms and functional significance","volume":"74","author":"Marincola","year":"2000","journal-title":"Adv. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2015.05.009_bib0355","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0002-9440(10)65321-7","article-title":"Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: Association with disease progression","volume":"154","author":"Kageshita","year":"1999","journal-title":"Am. J. Pathol."},{"issue":"11","key":"10.1016\/j.imlet.2015.05.009_bib0360","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/jnci\/94.11.805","article-title":"Cancer immunotherapy with peptide-based vaccines: What have we achieved? Where are we going?","volume":"94","author":"Parmiani","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.imlet.2015.05.009_bib0365","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-0-387-68969-2_20","article-title":"Regulatory T cells: A new frontier in cancer immunotherapy","volume":"622","author":"Barnett","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.imlet.2015.05.009_bib0370","doi-asserted-by":"crossref","DOI":"10.1186\/1756-8722-5-34","article-title":"Cytoreduction surgery reduces systemic myeloid suppressor cell populations and restores intratumoral immunotherapy effectiveness","volume":"5","author":"Predina","year":"2012","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.imlet.2015.05.009_bib0375","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00262-003-0443-2","article-title":"Derangement of immune responses by myeloid suppressor cells","volume":"53","author":"Serafini","year":"2004","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.imlet.2015.05.009_bib0380","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0065-230X(08)60827-1","article-title":"Immunosuppressive factors in human cancer","volume":"60","author":"Sulitzeanu","year":"1993","journal-title":"Adv. Cancer Res."},{"issue":"1\u20133","key":"10.1016\/j.imlet.2015.05.009_bib0385","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s12026-008-8087-0","article-title":"Cancer immunotherapy using listeria monocytogenes and listerial virulence factors","volume":"42","author":"Wood","year":"2008","journal-title":"Immunol. Res."},{"issue":"3","key":"10.1016\/j.imlet.2015.05.009_bib0390","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1083\/jcb.200205009","article-title":"The cell biology of listeria monocytogenes infection: The intersection of bacterial pathogenesis and cell-mediated immunity","volume":"158","author":"Portnoy","year":"2002","journal-title":"J. Cell Biol."},{"issue":"10","key":"10.1016\/j.imlet.2015.05.009_bib0395","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nri1461","article-title":"Immune responses to listeria monocytogenes","volume":"4","author":"Pamer","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.imlet.2015.05.009_bib0400","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00262-011-1002-x","article-title":"Targeting tumor vasculature with novel listeria-based vaccines directed against CD105","volume":"60","author":"Wood","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"issue":"9","key":"10.1016\/j.imlet.2015.05.009_bib0405","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.4049\/jimmunol.0803742","article-title":"An anti-vascular endothelial growth factor receptor 2\/fetal liver kinase-1 listeria monocytogenes anti-angiogenesis cancer vaccine for the treatment of primary and metastatic her-2\/neu+ breast tumors in a mouse model","volume":"182","author":"Seavey","year":"2009","journal-title":"J. Immunol."},{"issue":"19","key":"10.1016\/j.imlet.2015.05.009_bib0410","doi-asserted-by":"crossref","first-page":"8066","DOI":"10.1158\/0008-5472.CAN-08-0287","article-title":"Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature","volume":"68","author":"Maciag","year":"2008","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.imlet.2015.05.009_bib0415","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4161\/hv.22106","article-title":"Therapeutic vaccines: The ultimate personalized therapy?","volume":"9","author":"Gulley","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"issue":"11","key":"10.1016\/j.imlet.2015.05.009_bib0420","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.4049\/jimmunol.167.11.6471","volume":"167","author":"Gunn","year":"2001","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2015.05.009_bib0425","first-page":"454","article-title":"Listeria-based vaccines for cancer treatment","volume":"7","author":"Paterson","year":"2005","journal-title":"Curr. Opin. Mol. Ther."},{"issue":"5","key":"10.1016\/j.imlet.2015.05.009_bib0430","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nm0595-471","article-title":"A recombinant listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours","volume":"1","author":"Pan","year":"1995","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.imlet.2015.05.009_bib0435","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/sj.bjc.6604526","article-title":"Mage-b vaccine delivered by recombinant listeria monocytogenes is highly effective against breast cancer metastases","volume":"99","author":"Kim","year":"2008","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.imlet.2015.05.009_bib0440","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00262-004-0600-2","article-title":"What is needed for effective antitumor immunotherapy? Lessons learned using Listeria monocytogenes as a live vector for HPV-associated tumors","volume":"54","author":"Hussain","year":"2005","journal-title":"Cancer Immunol. Immunother."},{"issue":"11","key":"10.1016\/j.imlet.2015.05.009_bib0445","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2217\/imt.12.121","article-title":"How can cytoreduction surgery improve the prospects for cancer patients receiving immunotherapy?","volume":"4","author":"Judy","year":"2012","journal-title":"Immunotherapy"},{"issue":"1","key":"10.1016\/j.imlet.2015.05.009_bib0450","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jtcvs.2003.08.034","article-title":"Immuno-gene therapy with interferon-beta before surgical debulking delays recurrence and improves survival in a murine model of malignant mesothelioma","volume":"127","author":"Kruklitis","year":"2004","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"1","key":"10.1016\/j.imlet.2015.05.009_bib0455","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4049\/jimmunol.171.1.166","article-title":"CD28 and inducible costimulatory protein src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, bcl-xL, and IL-2 expression in primary human CD4T lymphocytes","volume":"171","author":"Parry","year":"2003","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.imlet.2015.05.009_bib0460","doi-asserted-by":"crossref","first-page":"745","DOI":"10.4161\/cbt.20557","article-title":"A positive-margin resection model recreates the postsurgical tumor microenvironment and is a reliable model for adjuvant therapy evaluation","volume":"13","author":"Predina","year":"2012","journal-title":"Cancer Biol. Ther."},{"issue":"6","key":"10.1016\/j.imlet.2015.05.009_bib0465","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ctrv.2011.11.008","article-title":"Adjuvant immunotherapy for non-small cell lung cancer","volume":"38","author":"Tucker","year":"2012","journal-title":"Cancer Treat. Rev."},{"issue":"6","key":"10.1016\/j.imlet.2015.05.009_bib0470","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1158\/1078-0432.CCR-04-1380","article-title":"Induction of an antigen cascade by diversified subcutaneous\/intratumoral vaccination is associated with antitumor responses","volume":"11","author":"Kudo-Saito","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.imlet.2015.05.009_bib0475","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/cgt.2011.56","article-title":"Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models","volume":"18","author":"Predina","year":"2011","journal-title":"Cancer Gene Ther."},{"issue":"2","key":"10.1016\/j.imlet.2015.05.009_bib0480","first-page":"206","article-title":"Characterization of surgical models of postoperative tumor recurrence for preclinical adjuvant therapy assessment","volume":"4","author":"Predina","year":"2012","journal-title":"Am. J. Transl. Res."},{"issue":"9","key":"10.1016\/j.imlet.2015.05.009_bib0485","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm.3286","article-title":"Inhibition of p300 impairs Foxp3(+) T regulatory cell function and promotes antitumor immunity","volume":"19","author":"Liu","year":"2013","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.imlet.2015.05.009_bib0490","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1158\/1078-0432.CCR-11-2121","article-title":"A live-attenuated listeria vaccine (ANZ-100) and a live-attenuated listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: Phase I studies of safety and immune induction","volume":"18","author":"Le","year":"2012","journal-title":"Clin. Cancer Res."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247815000772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247815000772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T14:27:18Z","timestamp":1537626438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247815000772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0165247815000772"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2015.05.009","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgical cytoreduction restores the antitumor efficacy of a Listeria monocytogenes vaccine in malignant pleural mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2015.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}